test

Manish Mital

@Braidwell Lp

Latest period2024 - Q3ReportedManaged Assets$3.528BTotal holdings81
Assets growth rate10.68%Assets growth rate (2-Q avg)6.71%Continuous growth in asset value3 quarters

Portfolio positions

This chart displays the top 10 holdings in Braidwell Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Braidwell Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.528B in assets, with a quarterly growth rate of 10.68% and a 2-quarter average growth rate of 6.71%. The portfolio is managed by Manish Mital, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
4050⤦Haemonetics Corp Mass
Recent Activity
0.31%
$10.638M
11.5M shares@ $0.93 avg price
ALECAlector Inc
Recent Activity
Decreased -9.34%
0.29%
$10.057M
2.158M shares@ $4.67 avg price
ZURAZura Bio Ltd
Recent Activity
New Position
0.29%
$10.04M
2.473M shares@ $4.06 avg price
PODDInsulet Corp
Recent Activity
New Position
0.29%
$9.892M
42,500 shares@ $232.75 avg price
NVRONevro Corp
Recent Activity
0.27%
$9.496M
1.699M shares@ $5.59 avg price
CSTLCastle Biosciences Inc
Recent Activity
Decreased -20.21%
0.27%
$9.468M
331,986 shares@ $28.53 avg price
XNCRXencor Inc
Recent Activity
New Position
0.27%
$9.38M
466,448 shares@ $20.11 avg price
JSPRJasper Therapeutics Inc
Recent Activity
New Position
0.26%
$9.091M
483,300 shares@ $18.81 avg price
BBIOBridgebio Pharma Inc
Recent Activity
Decreased -13.65%
0.22%
$7.597M
298,400 shares@ $25.46 avg price
LXEOLexeo Therapeutics Inc
Recent Activity
Decreased -47.28%
0.19%
$6.588M
728,777 shares@ $9.04 avg price